Clinically recurrent primary sclerosing cholangitis following liver transplantation: A time course

Liver Transplantation

Volumn 14, Issue 2, 2008, Pages 181-185

  Campsen, Jeffrey ^a   Zimmerman, Michael A ^a   Trotter, James F ^b   Wachs, Michael ^a   Bak, Thomas ^a   Steinberg, Tracy ^a   Kam, Igal ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

ADULT; ARTICLE; BILE DUCT CARCINOMA; CLINICAL EXAMINATION; COLD ISCHEMIA; ENTERITIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVER TRANSPLANTATION; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RECURRENT DISEASE; RETRANSPLANTATION; SURGICAL TECHNIQUE; SURVIVAL TIME; UNITED STATES; UNIVERSITY HOSPITAL;

CHOLANGITIS, SCLEROSING; COLORADO; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 39449110708     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21313     Document Type: Article

References (20)

1. Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gasteroenterology 1991; 100(pt 1):1319-1323.
2. Abu-Elmagd K, Malinchoc M, Dickson ER, Fung JJ, Murtaugh PA, Langworthy AL, et al. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet 1993;177:335-344.
3. Quigley EM, LaRusso NF, Ludwig J, Mac Sween RN, Birnie GG, Watkinson G. Familial occurrence of primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1983;85:1160-1165.
4. Bansi D, Chapman R, Fleming K. Antineutrophil cytoplasmic antibodies in chronic liver disease: prevalence, titre, specificity and IgG subclass. J Hepatol 1996;24:581-586.
5. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-933.
6. Gautam M, Cheruvattath R, et al. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006;12:1813-1824.
7. Abu-Elmagd K, Balan V. Recurrent primary sclerosing cholangitis: from an academic illusion to a clinic reality. Liver Transpl 2005;11:1326-1328.
8. Sheng R, Campbell WL, Zajko AB, Baron RL. cholangiographic features of biliary strictures after liver transplantation for primary sclerosing cholangitis: evidence of recurrent disease. AJR Am J Roentgenol 1996;166:1109-1113.
9. Marsh JW Jr, Iwatsuki S, Makowka L, Esquivel CO, Gordon RD, Todo S, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988;207:21-25.
10. Wiesner RH, Grambsch PM, Dickson ER, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10:430-436.
11. Jeyarajah DR, Netto GJ, Lee SP, Testa G, Abbasoglu O, Husberg BS, et al. Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process? Transplantation 1998; 66:1300-1306.
12. Levy C, Lindor KD. Primary sclerosing cholangitis: epidemiology, natural history, and prognosis. Semin Liver Dis 2006;26:22-30.
13. Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, et al. Liver transplantation for primary sclerosing cholangitis: a long term clinicopathological study. Hum Pathol 2003;34:1127-1136.
14. Brandseater B, Schrumf E, Bentdal O, Braband K, Smith HJ, Abildgaard A, et al. Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors. Liver Transpl 2005;11:1361-1369.
15. Vera A, Moledina S, Gunson B, Hubscher S, Mirza D, Olliff S, Neuberger J. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002;360:1943-1944.
16. Kugelmas M, Spiegelman P, Osgood M, Young D, Trotter J, Steinberg T, et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003;9:2003:727-732.
17. Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, et al. Liver transplantation using sirolimus and minimal corticosteroids (3-day taper). Liver Transpl 2001: 7:343-351.
18. Rodriguez-Luna H, Vargas HE. Natural history of hepatitis C and outcomes following liver transplantation. Minerva Gastroenterol Dietol 2004;50:51-59.
19. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Albert SR, Kremers WH, et al. Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-458.
20. Graziadei, IW, Wiesner RH, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999;30:1121-1127.